Nureca Limited concluded its 10th Annual General Meeting (AGM) on July 28, 2026, with shareholders approving all four resolutions — including the adoption of financial statements for the fiscal year ended March 31, 2026 and key changes to the Board of Directors. The meeting was held via Video Conferencing/Other Audio Visual Means (VC/OAVM), commencing at 11:30 AM IST and closing at 12:18 PM IST. The company subsequently filed the consolidated Scrutinizer's Report under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the outcome of remote e-voting and e-voting conducted during the meeting.

The e-voting window was open from July 25, 2026 (9:00 AM) to July 27, 2026 (5:00 PM), facilitated through Central Depository Services (India) Limited (CDSL). Members whose names appeared in the Register of Members as on the cut-off date of July 21, 2026 were entitled to vote. The total number of shareholders on the record date stood at 34,178. Of these, 2 shareholders from the Promoter and Promoter Group and 51 public shareholders attended the meeting through Video Conferencing. Mr. Prince Chadha of M/s P. Chadha & Associates was appointed as Scrutinizer to oversee the e-voting process and ensure fair and transparent proceedings.

Key Resolutions Passed

All four resolutions proposed at the AGM were passed with requisite majority. The following table summarises the resolutions transacted:

Detailed Voting Results

The Scrutinizer's consolidated report provided agenda-wise breakdowns of votes cast across shareholder categories. The results for each resolution are presented below.

Resolution 1 & 2 — Ordinary Business (Financial Statements Adoption & Director Reappointment)

Both ordinary resolutions recorded identical voting patterns. A total of 9,541,920 shares were held across all categories, with 6,502,150 votes polled, representing 68.14% of outstanding shares.

No invalid votes were recorded. The resolutions were passed with 99.9974% votes in favour and 0.0026% against.

Resolution 3 — Special Business (Reappointment of Managing Director)

For the reappointment of Saurabh Goyal as Managing Director, the Promoter & Promoter Group did not participate in voting, as they were interested parties. A total of 4,974 votes were polled out of 9,541,920 shares held.

No invalid votes were recorded. The resolution was passed with 96.64% votes in favour and 3.36% against.

Resolution 4 — Special Business (Appointment of Whole-time Director)

The appointment of Smita Goyal as Whole-time Director recorded an identical voting pattern to Resolution 3, with the Promoter & Promoter Group abstaining as interested parties.

No invalid votes were recorded. The resolution was passed with 96.64% votes in favour and 3.36% against.

Board Attendance and Management Presence

Saurabh Goyal, Chairman and Managing Director, chaired the meeting. Other directors present included Additional Director Smita Goyal, Independent Directors Vijay Kumar Sharma, Charu Singh, Ruchita Agarwal, and KK Bhasin. Charu Singh also served as Chairperson of the Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee. Independent Director Rupinder Tewari was absent due to a medical emergency, while Whole-time Director Rajinder Sharma was pre-occupied with other commitments. Key management personnel in attendance included Chief Financial Officer Chander Kant and Company Secretary Nishu Kansal. Internal Auditor Gagan Deep Singh of M/s MGSG & Associates and Secretarial Auditor Ajay Arora of M/s A. Arora & Co. were also present. Statutory Auditors M/s Singhi & Co., Chartered Accountants, expressed an unqualified opinion on the audit reports for FY26. The proceedings were conducted in compliance with the Companies Act, 2013, SEBI Listing Regulations, and circulars issued by the Ministry of Corporate Affairs (MCA) and SEBI.

Nureca Limited returned to profitability in the first quarter of FY27, reporting a consolidated net profit of ₹3.07 crore for the period ended June 30, 2026. This marks a recovery from the net loss of ₹6 crore posted in the quarter ended March 31, 2026. Revenue from operations rose to ₹40.34 crore, compared to ₹35.4 crore in the previous quarter, driven by the company's home healthcare and wellness products segment. The company achieved its highest quarterly sales and profitability in the last 16 quarters.

Financial Performance Overview

The Board of Directors approved the unaudited financial results at a meeting held on July 21, 2026. On a consolidated basis, the company reported an EBITDA of ₹5.2 crore for the quarter, a significant increase from the negative EBITDA of ₹4.7 crore in the previous quarter. Profit before tax stood at ₹4.43 crore. Gross margin was 39%, while operating margin improved to 8.7%. The Gross Merchandise Value (GMV) for the quarter was ₹51.8 crore, up from ₹49.7 crore in Q4 FY26. Nureca remains debt-free with net cash and investments of ₹110 crore.

Consolidated Results (Q1FY27)

Operational Highlights

The company reported an operating profit of ₹3.5 crore for Q1FY27, compared to ₹2.6 crore in the preceding quarter. On a standalone basis, the company reported a net profit of ₹2.43 crore for Q1FY27, reversing the net loss of ₹6.63 crore in Q4 FY26. Standalone revenue from operations increased to ₹40.40 crore from ₹35.41 crore in the quarter ended March 31, 2026.

Business Segment Performance

Nureca operates in a single business segment focused on home healthcare and wellness products. The sales mix for Q1 FY27 was predominantly online at 87.6%, with offline retail accounting for 12.4%. Online sales increased by 16% year-on-year, while offline retail revenue grew by 57% year-on-year. The company continues to expand its manufacturing capabilities, with revenue from in-house manufactured products contributing 27% in Q1 FY27 compared to 26% in FY26.